Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cytopenia × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Classical hematology 1

Conditions

Motor Activity 214 Breast Neoplasms 119 Neoplasms 93 Prostatic Neoplasms 33 Fatigue 29 Obesity 23 Colorectal Neoplasms 21 Lung Neoplasms 17 Colonic Neoplasms 15 Polycystic Ovary Syndrome 14 Ovarian Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphedema 11 Lymphoma 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Hematologic Neoplasms 9 Weight Loss 8 Multiple Myeloma 8 Leukemia 8 Cardiotoxicity 8 Brain Neoplasms 8 Pancreatic Neoplasms 7 Insulin Resistance 7 Carcinoma, Non-Small-Cell Lung 7 Overweight 6 Cognitive Dysfunction 6 Sarcopenia 5 Peripheral Nervous System Diseases 5 Lymphoma, Follicular 5

Interventions

ON 01910 2 Biopsy 2 AP 1903 reagent 2 thymoglobulin 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 decitabine and cedazuridine drug combination 1 cedazuridine 1 Therapeutics 1 Specimen Handling 1 Sertraline 1 Pluvicto 1 Peripheral Blood Stem Cell Transplantation 1 Metformin 1 Interleukin-8 1 Immunotherapy, Adoptive 1 IDO-1 inhibitor LY3381916 1 HuMax-IL8 1 Granulocyte Colony-Stimulating Factor 1 Genetic Counseling 1 Filgrastim 1 Exercise 1 Emapalumab 1 Decitabine 1 DNA 1 Cyclophosphamide 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1 Bone Marrow Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06773871 2025-08-19

HemEx

Rigshospitalet, Denmark

Phase NA Recruiting

Classical hematologyMyeloid

Cytopenia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡